Which thyroid medication is known to cause papillary thyroid carcinoma in children?

Which thyroid medication is known to cause papillary thyroid carcinoma in children?

• A. Methimazole
• B. Levothyroxine
• C. Propylthiouracil
• D. Liothyronine

Answer: (B)

Papillary thyroid carcinoma in children is most clearly linked to exposure to ionizing radiation to the head and neck during childhood. The medications listed are used to manage thyroid hormone levels and do not initiate malignant transformation in thyroid tissue. Levothyroxine provides thyroid hormone replacement (or can be used to suppress TSH in some cancer management contexts), but it is not known to cause papillary thyroid carcinoma. The other drugs—methimazole and propylthiouracil, which decrease thyroid hormone production, and liothyronine, a T3 supplement—do not have a known causal link to this cancer in children. In short, among these options, none are known to cause papillary thyroid carcinoma; radiation exposure is a more established risk factor.

Papillary thyroid carcinoma in children is most clearly linked to exposure to ionizing radiation to the head and neck during childhood. The medications listed are used to manage thyroid hormone levels and do not initiate malignant transformation in thyroid tissue. Levothyroxine provides thyroid hormone replacement (or can be used to suppress TSH in some cancer management contexts), but it is not known to cause papillary thyroid carcinoma. The other drugs—methimazole and propylthiouracil, which decrease thyroid hormone production, and liothyronine, a T3 supplement—do not have a known causal link to this cancer in children. In short, among these options, none are known to cause papillary thyroid carcinoma; radiation exposure is a more established risk factor.